FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example ClinicalUseDefinition/example-interaction (Narrative)

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format.


Generated Narrative: ClinicalUseDefinition

Resource ClinicalUseDefinition "example-interaction"

StructureDefinition Work Group: brr

type: interaction

subject: MedicinalProductDefinition/example

interaction

interactant

item: alphaconazole (interactant#alphaconazole)

interactant

item: betaconazole (interactant#betaconazole)

type: Inhibitor (interactionsType#Inhibitor)

Effects

-Concept
*Increased plasma concentration ()

management: Careful monitoring of dose ()


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.